This result is in line with previous studies showing an increased expression of proinflammatory molecules in the CSF of MS patients during acute relapses, including IL-1β and CCL5/RANTES (Rossi et al., 2012; Mori et al., 2016). Here, CCL5 is linked to myeloid sarcoma.